{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:52:22Z","timestamp":1778586742253,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T00:00:00Z","timestamp":1499212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T00:00:00Z","timestamp":1499212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["127421A"],"award-info":[{"award-number":["127421A"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCSF PKD Center of Excellence","award":["7027335"],"award-info":[{"award-number":["7027335"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0641-3","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T11:45:01Z","timestamp":1499255101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Wen-Ching","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tea","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine A.","family":"Chesla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meyeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,5]]},"reference":[{"key":"641_CR1","unstructured":"PKD Foundation website poLa. \n                    www.pkdcure.org\n                    \n                  ."},{"issue":"4","key":"641_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrneph.2009.13","volume":"5","author":"T Ecder","year":"2009","unstructured":"Ecder T, Schrier RW. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol. 2009;5(4):221\u20138.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"641_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ckj\/sfv060","volume":"8","author":"A Baker","year":"2015","unstructured":"Baker A, King D, Marsh J, et al. Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians. Clin Kidney J. 2015;8(5):531\u20137.","journal-title":"Clin Kidney J"},{"issue":"24","key":"641_CR4","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","volume":"371","author":"RW Schrier","year":"2014","unstructured":"Schrier RW, Abebe KZ, Perrone RD, et al. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med. 2014;371(24):2255\u201366.","journal-title":"N Engl J Med"},{"issue":"13","key":"641_CR5","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1001\/archinte.160.13.1947","volume":"160","author":"JA Blumenthal","year":"2000","unstructured":"Blumenthal JA, Sherwood A, Gullette ED, et al. Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning. Arch Intern Med. 2000;160(13):1947\u201358.","journal-title":"Arch Intern Med"},{"issue":"10","key":"641_CR6","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.jacc.2014.12.039","volume":"65","author":"WB Farquhar","year":"2015","unstructured":"Farquhar WB, Edwards DG, Jurkovitz CT, Weintraub WS. Dietary sodium and health: more than just blood pressure. J Am Coll Cardiol. 2015;65(10):1042\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"641_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2215\/CJN.03950510","volume":"6","author":"CJ Wang","year":"2011","unstructured":"Wang CJ, Creed C, Winklhofer FT, Grantham JJ. Water prescription in autosomal dominant polycystic kidney disease: a pilot study. Clin J Am Soc Nephrol. 2011;6(1):192\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"641_CR8","doi-asserted-by":"crossref","unstructured":"Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882\u2013887.e881.","DOI":"10.1016\/j.amjmed.2011.12.013"},{"key":"641_CR9","doi-asserted-by":"crossref","unstructured":"CDC. US adults are lax on meeting national exercise guidelines. JAMA 2013;309(23):2431\u20132431.","DOI":"10.1001\/jama.2013.6687"},{"issue":"25","key":"641_CR10","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407\u201318.","journal-title":"N Engl J Med"},{"issue":"1","key":"641_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ki.2013.23","volume":"84","author":"CJ Wang","year":"2013","unstructured":"Wang CJ, Grantham JJ, Wetmore JB. The medicinal use of water in renal disease. Kidney Int. 2013;84(1):45\u201353.","journal-title":"Kidney Int"},{"issue":"2","key":"641_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jval.2014.12.013","volume":"18","author":"VL Morrison","year":"2015","unstructured":"Morrison VL, Holmes EA, Parveen S, et al. Predictors of self-reported adherence to antihypertensive medicines: a multinational, cross-sectional survey. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2015;18(2):206\u201316.","journal-title":"Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"issue":"9","key":"641_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/sj.jhh.1001721","volume":"18","author":"S Ross","year":"2004","unstructured":"Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004;18(9):607\u201313.","journal-title":"J Hum Hypertens"},{"key":"641_CR14","unstructured":"Kleinman A. The Illness Narratives: Suffering,Healing, and the Human Condition. New York, Basic Books. 1988."},{"key":"641_CR15","doi-asserted-by":"crossref","unstructured":"Benner P. The tradition and skill of interpretive phenomenology in sutdying health illness and caring practices. In Benner,P. (Ed.) Interpretive phenomenology.. Thousand Oaks (Sage). 1994:99\u2013127.","DOI":"10.4135\/9781452204727.n6"},{"issue":"12","key":"641_CR16","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.2337\/diacare.23.12.1780","volume":"23","author":"CA Chesla","year":"2000","unstructured":"Chesla CA, Skaff MM, Bartz RJ, Mullan JT, Fisher L. Differences in personal models among Latinos and European Americans: implications for clinical care. Diabetes Care. 2000;23(12):1780\u20135.","journal-title":"Diabetes Care"},{"key":"641_CR17","doi-asserted-by":"crossref","unstructured":"Grubbs V, Tuot DS, Powe NR, O'Donoghue D, Chesla CA. System-level barriers and facilitators for foregoing or withdrawing dialysis: a qualitative study of nephrologists in the United States and England. Am J Kidney Dis. 2017;","DOI":"10.1053\/j.ajkd.2016.12.015"},{"key":"641_CR18","volume-title":"An introduction to qualitative research interviewing","author":"S Kvale","year":"1996","unstructured":"Kvale S. An introduction to qualitative research interviewing. 1996."},{"key":"641_CR19","doi-asserted-by":"crossref","unstructured":"Braun VC, V. Using thematic analysis in psychology. Qualitative Research in Psychology, 3: 77\u2013101, 2006. 2006(3):77\u2013101.","DOI":"10.1191\/1478088706qp063oa"},{"issue":"1","key":"641_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pec.2008.01.021","volume":"72","author":"RA Bell","year":"2008","unstructured":"Bell RA, Kravitz RL. Physician counseling for hypertension: what do doctors really do? Patient Educ Couns. 2008;72(1):115\u201321.","journal-title":"Patient Educ Couns"},{"issue":"10","key":"641_CR21","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/nep.12675","volume":"21","author":"TX Chua","year":"2016","unstructured":"Chua TX, Prasad NS, Rangan GK, Allman-Farinelli M, Rangan AM. A systematic review to determine the most effective interventions to increase water intake. Nephrology (Carlton). 2016;21(10):860\u20139.","journal-title":"Nephrology (Carlton)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0641-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-017-0641-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0641-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T14:35:37Z","timestamp":1589466937000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0641-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["641"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0641-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,5]]},"assertion":[{"value":"5 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the UCSF Committee on Human Research (CHR) Institutional Review Board. CHR number: 15\u201317,008. Signed informed consent to digitally record and extract data from interviews for analysis was obtained from each participant prior to the interview.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Signed informed consent to digitally record and publish the interviews in a de-identified manner was obtained from each participant prior to the interview.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Meyeon Park is the UCSF Site PI for the Tolvaptan REPRISE study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"214"}}